Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds
Shares in Moderna Inc. dropped at least 5% as trading opened Monday after a delay in the decision to approve the COVID-19 vaccine for adolescents ages 12-17.
via DigioNews Markets
Note : I Hope My My New News Article : Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds
0 Comments